Skip to content

Natural psychedelics in the treatment of depression; a review focusing on neurotransmitters.

Samane Jahanabadi, Shayan Amiri, Mehdi Karkeh-Abadi, Ali Razmi

Fitoterapia September 1, 2023 DOI: 10.1016/j.fitote.2023.105620 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Review Peer reviewed
Topics Depression DMT Psilocybin
Keywords Natural psychedelics Neurotransmission system Psychedelic medicine Mental health treatment Alternative antidepressants Neuroscience research
Citations 14
Key findings Natural psychedelics exert neurobiological therapeutic effects through multiple neurotransmission systems, offering novel mechanisms for treating depression.

Abstract

Natural psychedelic compounds are emerging as potential novel therapeutics in psychiatry. This review will discuss how natural psychedelics exert their neurobiological therapeutic effects, and how different neurotransmission systems mediate the effects of these compounds. Further, current therapeutic strategies for depression, and novel mechanism of action of natural psychedelics in the treatment of depression will be discussed. In this review, our focus will be on N, N-dimethyltryptamine (DMT), reversible type A monoamine oxidase inhibitors, mescaline-containing cacti, psilocybin/psilocin-containing mushrooms, ibogaine, muscimol extracted from Amanita spp. mushrooms and ibotenic acid.

Comparable studies

Other narrative reviews on DMT for depression, most cited first.

Explore topics

By condition and practice